Correlation Between Lyra Therapeutics and Enliven Therapeutics

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Enliven Therapeutics, you can compare the effects of market volatilities on Lyra Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Enliven Therapeutics.

Diversification Opportunities for Lyra Therapeutics and Enliven Therapeutics

-0.26

Correlation Coefficient

Lyra Therapeutics  Enliven Therapeutics

Very good diversification

The 3 months correlation between Lyra and Enliven is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Enliven Therapeutics go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Enliven Therapeutics

Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Enliven Therapeutics. In addition to that, Lyra Therapeutics is 2.93 times more volatile than Enliven Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.19 per unit of volatility. If you would invest  2,765  in Enliven Therapeutics on September 3, 2024 and sell it today you would lose (327.00) from holding Enliven Therapeutics or give up 11.83% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Enliven Therapeutics

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Enliven Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Lyra Therapeutics and Enliven Therapeutics

The main advantage of trading using opposite Lyra Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.

The idea behind Lyra Therapeutics and Enliven Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.